A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene.
By A. Dumitrescu, X. Liao, T. B. Best, K. Brockmann, S. Refetoff. American Journal of Human Genetics, 2004
668 citations recorded by the source corpus.
Subfields: Biochemistry, Endocrinology, Diabetes and Metabolism, Genetics
View Paper: https://www.semanticscholar.org/paper/a8dd598696918c3d6266c012ec74f05760ffdc90
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
In Endocrinology, Diabetes and Metabolism
In Genetics
Citations in the corpus
- Thyroid hormone regulation of metabolism. (2014, background): “The MCT8 gene is located on the X chromosome (66, 84), and males with MCT8 gene mutations have neurologic abnormalities including dystonia and developmental delay, with progression to quadriplegia (18).”
- Mechanisms of thyroid hormone action. (2012, positive): “When MCT8 was sequenced in these patients, inactivating mutations were identified in some individuals (54, 55).”
- Thyroid hormone receptors in brain development and function (2007, background): “To what extent deficient transfer of T 3 from glial cells to neurons plays a part in this syndrome is a matter of debate”
- Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014, positive): “These individuals have peripheral hypermetabolism and abnormal serum thyroid levels with elevated serum T3, low serum T4, and slightly high TSH (486,500,501).”